Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Exclusion Criteria

• •Ambulatory with a Life expectancy of \< 1 years
• •Inability to take dual antiplatelet or anticoagulants, hypersensitivity or allergy to aspirin or clopidogrel
• •Unable to tolerate right heart catheterization
• •Pulmonary artery aneurysm, moderate or greater PA stenosis or other PA anatomy that would prevent safe or proper use of the study device
• •Severe aortic, mitral or pulmonary valve regurgitation
• •Tricuspid regurgitation in conjunction with the presence of cirrhosis or congestive hepatopathy
• •Clot or Thrombus in any potential target ablation zone (right, left or main pulmonary artery)